Croconic acid disodium

Croconic acid disodium (Nacr) 是一种赖氨酸巴豆酰化 (Kcr) 激活剂和电活性材料,可降低 HDAC2、HDAC3、SIRT1、SIRT3 的表达并提高 EP300、CITED1、ACSS2、DPF2、CDYL、MLLT3、YEATS2 的表达,同时提升细胞内巴豆酰辅酶 A 含量及整体组蛋白赖氨酸巴豆酰化水平,从而促进牛成纤维细胞生长、调控细胞周期进程并抑制牛成纤维细胞凋亡 (apoptosis),还可提高牛体细胞核移植胚胎的囊胚发育效率,并通过钠-锂离子交换发生可逆的嵌锂/脱锂反应,因此可用于细胞生长促进的相关研究。
产品编号: MS-O26398 纯度: 99.98% CAS No.: 14379-00-1 分子式: C5Na2O5 分子量: 186.03
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
询价
200mg
询价
询价

产品描述

Croconic acid disodium (Nacr) 是一种赖氨酸巴豆酰化 (Kcr) 激活剂和电活性材料,可降低 HDAC2、HDAC3、SIRT1、SIRT3 的表达并提高 EP300、CITED1、ACSS2、DPF2、CDYL、MLLT3、YEATS2 的表达,同时提升细胞内巴豆酰辅酶 A 含量及整体组蛋白赖氨酸巴豆酰化水平,从而促进牛成纤维细胞生长、调控细胞周期进程并抑制牛成纤维细胞凋亡 (apoptosis),还可提高牛体细胞核移植胚胎的囊胚发育效率,并通过钠-锂离子交换发生可逆的嵌锂/脱锂反应,因此可用于细胞生长促进的相关研究。

生物实验数据

生物活性 Croconic acid disodium (Nacr) is a lysine crotonylation (Kcr) activator and electroactive material that decreases the expression of HDAC2, HDAC3, SIRT1, and SIRT3 while increasing the expression of EP300, CITED1, ACSS2, DPF2, CDYL, MLLT3, and YEATS2, elevates intracellular crotonyl-CoA levels and global histone lysine crotonylation, promotes bovine fibroblast growth, regulates cell cycle progression, and inhibits bovine fibroblast apoptosis, enhances the blastocyst development efficiency of bovine somatic cell nuclear transfer embryos, and undergoes reversible lithium insertion/deinsertion via sodium-lithium ion exchange, and can therefore be used for research related to cell growth promotion.
体外研究
(In Vitro)

Croconic acid disodium (2.5-10 mM; 4-8 h) 可提高牛成纤维细胞的细胞密度并维持其活力。
Croconic acid disodium (2.5-10 mM; 4-8 h) 可显著提高牛成纤维细胞的增殖速率。
Croconic acid disodium (2.5-10 mM; 8 h) 可极显著上调牛成纤维细胞中的 PCNA、CDK1、MK167 及 CDK2 的信使核糖核酸表达水平,并下调 CDKN1A、CDKN2A 的表达。
Croconic acid disodium (2.5-10 mM; 8 h) 可上调牛成纤维细胞中 CDK4,CDK6,CCNB1,CCNA2,CCNE2,CCND1 的 mRNA 表达量。
Croconic acid disodium (2.5-10 mM; 8 h) 可下调牛成纤维细胞中的 BAD,CYCS,CASP3,CASP9 基因表达并上调 BCL2,BCL-XL 基因表达。
Croconic acid disodium (2.5-10 mM; 8 h) 对牛成纤维细胞中的 Kcr 写入基因 (EP300、CITED1、ACSS2) 和读取基因 (DPF2、CDYL、MLLT3、YEATS2) 的上调作用最为显著,同时可下调 Kcr 擦除基因 (HDAC2、HDAC3、SIRT1、SIRT3)。
Croconic acid disodium (2.5-10 mM; 8 h) 可降低牛成纤维细胞的 G0/G1 期比例,同时提高 S 期和 G2/M 期细胞比例 (相较于对照组水平),从而促进细胞周期进程。
Croconic acid disodium (2.5-10 mM; 8 h) 可显著降低牛成纤维细胞中总凋亡细胞的比例。
Croconic acid disodium (5 mM; 8 h) 可显著提高牛成纤维细胞内的巴豆酰辅酶 A 水平。
Croconic acid disodium (5 mM; 8 h) 可显著提高牛成纤维细胞中整体组蛋白巴豆酰化及 H3K9 巴豆酰化水平。
Croconic acid disodium (5 mM; added to cell culture medium; single dose; 8 hours) 处理牛耳尖成纤维细胞可显著提高所得体细胞核移植胚胎的囊胚发育率至 38.1%。
Croconic acid disodium (110 次充放电循环;0.1-6 C 电流密度) 表现出优于更大尺寸 CADS 微柱和微线的锂离子电池性能。

Cell Viability Assay

Cell Line: bovine fibroblasts
Concentration: 2.5, 5, 7.5, 10 mM
Incubation Time: 4 h, 8 h, 12 h
Result: Significantly reduced cell density at 5 mM, 7.5 mM, and 10 mM after 4 h.
Significantly reduced viable cell proportion only at 10 mM after 4 h.
Significantly increased cell density at 5 mM, reduced cell density at 7.5 mM and 10 mM, maintained viable cell proportion at 5 mM, reduced viable cell proportion at 7.5 mM and 10 mM, and showed no significant effect at 2.5 mM on either measure after 8 h.
Significantly reduced cell density and viable cell proportion at all concentrations after 12 h.

Cell Proliferation Assay

Cell Line: bovine fibroblasts
Concentration: 2.5, 5, 7.5, 10 mM
Incubation Time: 4 h, 8 h, 12 h
Result: Showed no significant effect on percentage of cells in DNA replication at 2.5 mM and 7.5 mM, significantly increased this percentage at 5 mM, and significantly decreased this percentage at 10 mM after 4 h.
Significantly decreased percentage of cells in DNA replication at 2.5 mM, 7.5 mM, and 10 mM, significantly increased this percentage at 5 mM after 8 h.
Significantly decreased percentage of cells in DNA replication only at 10 mM, showed no effect at 2.5 mM, 5 mM, and 7.5 mM after 12 h.

Real Time qPCR

Cell Line: bovine fibroblasts
Concentration: 2.5, 5, 7.5, 10 mM
Incubation Time: 8 h
Result: Significantly upregulated mRNA expression of PCNA, CDK1, MK167, and CDK2, and significantly downregulated mRNA expression of CDKN1A and CDKN2A at 2.5 mM, 5 mM, and 7.5 mM, with most significant effects at 5 mM.
Downregulated mRNA expression of PCNA, CDK1, MK167, and CDK2, and upregulated mRNA expression of CDKN1A and CDKN2A at 10 mM.\nSignificantly upregulated mRNA expression of CDK4, CDK6, CCNB1, CCNA2, CCNE2, and CCND1 at 2.5 mM, 5 mM, and 7.5 mM.
Showed no effect on the expression of these genes at 10 mM.\nDownregulated mRNA expression of proapoptotic genes BAD, CYCS, CASP3, and CASP9, and upregulated mRNA expression of antiapoptotic genes BCL2 and BCL-XL at 2.5 mM and 5 mM.
Upregulated mRNA expression of proapoptotic genes and downregulated mRNA expression of antiapoptotic genes at 7.5 mM and 10 mM.\nUpregulated mRNA expression of Kcr writer genes EP300, CITED1, and ACSS2, and downregulated mRNA expression of Kcr eraser genes HDAC2, HDAC3, SIRT1, and SIRT3 at all concentrations.
Upregulated mRNA expression of Kcr reader genes DPF2, CDYL, MLLT3, and YEATS2 at 2.5 mM and 5 mM, with most significant effects at 5 mM.

Cell Cycle Analysis

Cell Line: bovine fibroblasts
Concentration: 2.5, 5, 7.5, 10 mM
Incubation Time: 4 h, 8 h, 12 h
Result: Significantly reduced G0/G1 phase cell proportion (65.05% vs. control 72.84%) and increased S phase cell proportion (10.58% vs. control 7.11%) at 5 mM, decreased S phase cell proportion at 10 mM, and showed no notable effect at other concentrations after 4 h.
Increased S phase cell proportion to 8.84% and 8.37% respectively (vs. control 7.98% and 7.89% respectively), increased G2/M phase cell proportion to 15.59% and 15.16% respectively (vs. control 12.93% for both), and significantly reduced G0/G1 phase cell proportion at 5 mM and 7.5 mM after 8 h.
Increased G0/G1 phase cell proportion and decreased S and G2/M phase cell proportions at all concentrations after 12 h.

Apoptosis Analysis

Cell Line: bovine fibroblasts
Concentration: 2.5, 5, 7.5, 10 mM
Incubation Time: 4 h, 8 h, 12 h
Result: Significantly reduced total apoptotic cell proportion from control 18.6% to 16% at 2.5 mM, to 12.61% at 5 mM, to 13.18% at 7.5 mM, and to 13.6% at 10 mM after 4 h.
Significantly reduced total apoptotic cell proportion from control 21.44% to 10.42% (early apoptosis reduced from 3.67% to 2.53%, late apoptosis reduced from 17.77% to 7.89%) at 5 mM, reduced total apoptotic cell proportion to 13.18% at 7.5 mM after 8 h.
Increased total apoptotic cell proportion at all concentrations after 12 h.

ELISA Assay

Cell Line: bovine fibroblasts
Concentration: 5 mM
Incubation Time: 8 h
Result: Significantly increased intracellular crotonyl-CoA content compared to control.

Immunofluorescence

Cell Line: bovine fibroblasts
Concentration: 5 mM
Incubation Time: 8 h
Result: Significantly increased overall pan-Kcr fluorescence intensity and specifically increased H3K9cr fluorescence intensity compared to control.
性状 固体
颜色 Light yellow to yellow

化学信息

分子量 186.03
分子式 C5Na2O5
CAS No. 14379-00-1
别名 Nacr

储存&溶解度

储存方式

Store at room temperature, keep dry and cool

In solvent -80°C 1 year
-20°C 6 months
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

H2O 中的溶解度 : 50 mg/mL (268.77 mM; 超声助溶 (<60°C))

可选溶剂浓度1 mg5 mg10 mg25 mg
H2O1 mM5.3755 mL26.8774 mL53.7548 mL134.3869 mL
5 mM1.0751 mL5.3755 mL10.7510 mL26.8774 mL
10 mM0.5375 mL2.6877 mL5.3755 mL13.4387 mL
15 mM0.3584 mL1.7918 mL3.5837 mL8.9591 mL
20 mM0.2688 mL1.3439 mL2.6877 mL6.7193 mL
25 mM0.2150 mL1.0751 mL2.1502 mL5.3755 mL
30 mM0.1792 mL0.8959 mL1.7918 mL4.4796 mL
40 mM0.1344 mL0.6719 mL1.3439 mL3.3597 mL
50 mM0.1075 mL0.5375 mL1.0751 mL2.6877 mL
60 mM0.0896 mL0.4480 mL0.8959 mL2.2398 mL
80 mM0.0672 mL0.3360 mL0.6719 mL1.6798 mL
100 mM0.0538 mL0.2688 mL0.5375 mL1.3439 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 1 year; -20°C, 6 months。-80°C储存时,请在1年内使用, -20°C储存时,请在6个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础